Publicaciones
-
Barneda-Zahonero B, Collazo O, Azagra A, Fernández-Duran I, Serra-Musach J, Islam AB, Vega-García N, Malatesta R, Camós-Guijosa M, Gómez A, Román-González L, Vidal A, López-Bigas N, Villanueva A, Esteller M and Parra M.
The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma
CELL DEATH & DISEASE . 6: 1635. Nº de citas: 41
-
Niemeyer CM, Loh ML, Cseh A, Cooper T, Dvorak CC, Chan R, Xicoy B, Germing U, Kojima S, Manabe A, Dworzak M, De Moerloose B, Starý J, Smith OP, Masetti R, Català-Temprano A, Bergstraesser E, Ussowicz M, Fabri O, Baruchel A, Cavé H, Zwaan M, Locatelli F, Hasle H, van den Heuvel-Eibrink MM, Flotho C and Yoshimi A.
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia
HAEMATOLOGICA . 100(1): 17-22. Nº de citas: 34
-
Marina Caballero Bellón, Bobillo-Perez S, Català-Temprano A, Alonso-Saladrigues A, Valls-Lafon A, Rives-Solà S and Jordán-García I.
Role of procalcitonin, C reactive protein and ferritin in cytokine release syndrome after CAR T-cell therapy in children and young adults.
Biomarkers . : 1-13.
-
Romero-Moya D, Pera J, Marin-Bejar O, Torralba-Sales E, Murillo-Sanjuán L, Diaz-de-Heredia C, Montoro J, Rodríguez-Ubreva J, Liquori A, Cervera J, Wlodarski MW, Català-Temprano A and Giorgetti A.
Multiple phenotypes and epigenetic profiles in a three-generation family history with GATA2 deficiency.
Leukemia . : .